Global Anti-Inflammatory Cytokines Market: Market Outlook
Cytokines are categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer. According to the National Cancer Institute, it is estimated to diagnose more than 1 million cases of cancer in the U.S. alone. Hence, the increasing treatment adoption rate is expected to enhance global anti-inflammatory cytokines market growth in the coming decade.
Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5661
What strategies are the Key Players adopting for Increasing their Market Share in the Global Anti-Inflammatory Cytokines Market?
The manufacturers involved in the production of anti-inflammatory cytokines drugs by portfolio expansion strategies for increasing their market share in the global anti-inflammatory cytokines market. Key players are expanding their manufacturing facilities to serve the increasing demand for anti-inflammatory cytokines.
- In January 2021, Emergent BioSolutions and Humanigen have signed an agreement for development and manufacturing of drug called Lenzilumab. This drug is designed to prevent and treat an immune hyper-response of the cytokine storm.
- In January 2021, Tetra Bio-pharma received approval from the U.S. Food and Drug Administration (FDA) to begin its Phase 1 trial with human subjects for its investigational therapeutic drug.
- In July 2020, Derm-Biome Pharmaceutical announced that it raised pre-seed funding of US$ 500,000 along with Pan-Biome Pharmaceutical to develop medicines used in treatment for chronic inflammatory diseases including anti-inflammatory cytokines.
Pre Book this report: https://www.factmr.com/checkout/5661
Why is the U.S. a Big Market for Global Anti-Inflammatory Cytokines Market?
North America region is expected to dominate the global anti-inflammatory cytokines market during the forecast period. Whereas, in North America, the majority of the market share is of the U.S. in global anti-inflammatory cytokines market. The country has a large prevalence of cancer and other skin disorders creating it a large market for anti-inflammatory cytokines.
On the other hand, there is a significant number of key players present in the U.S. contributing large revenue towards global anti-inflammatory cytokines market. The high rate of approval and commercialization of anti-inflammatory cytokines drug will have a positive impact on market growth. There is significant rise of geriatric population in the U.S suffering from chronic disorders like cancer, infectious diseases and others. Hence, U.S. tends to be a key country for global anti-inflammatory cytokines market growth.
Key Segments of Global Anti-Inflammatory Cytokines Market Covered in the Report
Based on drug, the Global Anti-Inflammatory Cytokines Market has been segmented as
- Interleukin-1 receptor antagonist
Based on the route of administration, the Global Anti-Inflammatory Cytokines Market has been segmented as
Based on the indication, the Global Anti-Inflammatory Cytokines Market has been segmented as
- Graft-vs-host disease
- Cystic Fibrosis
- Cardiovascular diseases
- Adipose tissue metabolism and obesity
- Infectious diseases
Based on the distribution channel, the Global Anti-Inflammatory Cytokines Market has been segmented as
- Institutional Sales
- Speciality Clinics
- Research Institutes
- Retail Sales
- Retail Pharmacies
- Online Pharmacies
Based on the region, the Global Anti-Inflammatory Cytokines Market has been segmented as
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa
Enquire before buying: https://www.factmr.com/connectus/sample?flag=EB&rep_id=5661
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates